Brand Drug Makers Protested Cures Exclusivity Provisions Requiring NIH Donations

Provisions in the January version of the 21st Century Cures draft that allowed manufacturers to transfer 12 months of exclusivity to another product were put on the chopping block after brand-name drug makers railed against language requiring companies to donate a percentage of their profits from the products to the National Institutes of Health, according to an industry expert on the topic. However, a infectious disease research and patient advocacy group supported the provision, noting the group made a similar...